Supplemental Q10 Extends Life in End-Stage Cancer Patients

Byron's Comments:

Right now phamacetical companies are bilking families of end-stage cancer patients hundreds of thousands of dollars to entend life for six months. It appears Q10 and a few other antioxidants can do the same for very little cost.

Study Title:

Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study.

Study Abstract:

This pilot study evaluated the survival of patients with end-stage cancer who received supplements of coenzyme Q(10) and a mixture of other antioxidants (e.g. vitamin C, selenium, folic acid and beta-carotene). During a period of 9 years, 41 patients who had end-stage cancer were included. Forty patients were followed until death and one patient was lost to follow-up and presumed dead. Primary cancers were located in the breast, brain, lungs, kidneys, pancreas, oesophagus, stomach, colon, prostate, ovaries and skin. The median predicted survival time was calculated from Kaplan-Meier curves for each patient at inclusion. Median predicted survival was 12 months (range 3 - 29 months), whereas median actual survival was 17 months (1 - 120 months), which is > 40% longer than the median predicted survival. Mean actual survival was 28.8 months versus 11.9 months for mean predicted survival. Ten patients (24%) survived for less time than predicted, whereas 31 (76%) survived for longer. Treatments were very well tolerated with few adverse effects.

Study Information:

Hertz N, Lister RE. Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J Int Med Res.  2009 December  ;37(6):1961-71.
Arnakkegårds alle 50, Vipperoed, Denmark.

My cart is empty.   View Cart |  Login

• How Protein Helps Weight Loss
  
• The Five Rules of The Leptin Diet
  
• The Facts on Magnesium Stearate
  
• What is Leptin?
  
• Taking Q10 for a Test Drive – Is Ubiquinol Better?